Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds (BQ-01-07-ARVO)

This study has been completed.
Information provided by:
Instituto de Olhos de Goiania Identifier:
First received: November 26, 2007
Last updated: November 25, 2008
Last verified: November 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Estimated Primary Completion Date: No date given